SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Tables)

6 Months Ended

Sep. 30, 2022

Accounting Policies [Abstract]

SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

The following table is the reconciliation of the presentation and disclosure of cash, cash equivalents, marketable securities by major security type and restricted cash (in thousands):

		September 30, 2022				March 31, 2022
Cash and cash equivalents		$	29,829			$	80,242

Marketable securities :
Marketable debt securities
Corporate debt securities			4,762				-
US government securities			10,855				-
Mutual funds			17,000				-
Total marketable securities		$	32,617			$	-

Restricted cash			10,106				9,988
Total cash, cash equivalents, short-term investments and restricted cash		$	72,551			$	90,230

SUMMARY OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED LOSSES

The following table summarizes our short-term marketable securities with unrealized losses as of September 30, 2022, aggregated by major security type :

(in thousands)		Fair Value				Unrealized Losses
Corporate debt securities			4,762				(36	)
US government securities			10,855				(2	)
Mutual Funds			17,000				-
Total short-term marketable securities		$	32,617			$	(38	)

SCHEDULE OF SEGMENT FINANCIAL INFORMATION BY BUSINESS SEGMENT

The following table summarizes segment financial information by business segment for the three and six months ended September 30, 2022:

(in thousands)		Beyond Air				Beyond Cancer
Cash, cash equivalents, marketable securities and certain restricted cash		$	40,754			$	24,291
All other assets			16,406				588
Total liabilities			(17,747	)			(640	)
Net assets – net liabilities		$	39,413			$	24,239
Non-controlling interests		$	-			$	4,847

Net loss for the six months ended September 30, 2022		$	(16,703	)		$	(7,749	)
Operating activities included in net loss:
Depreciation and amortization			232				4
Stock-based compensation expense			4,880				4,458

Cash used in operations		$	(12,635	)		$	(3,425	)

(in thousands)		Beyond Air				Beyond Cancer
Net loss for the three months ended September 30, 2022		$	(8,650	)		$	(4,148	)
Operating activities included in net loss:
Depreciation and amortization			112				2
Stock-based compensation expense			2,484				2,231

Cash used in operations		$	(7,123	)		$	(2,097	)

SCHEDULE OF PROPERTY AND EQUIPMENT USEFUL LIFE OF ASSETS

Property and equipment are stated at cost less accumulated depreciation and accumulated amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful life of the assets as follows:

Computer equipment	Three years
Furniture and fixtures	Five years
Clinical and medical equipment	Five years
Equipment deployable as part of a service offering	Five years
Leasehold improvements	Shorter of term of lease or estimated useful life of the asset